Apolipoprotein e gene polymorphism and Alzheimer's disease in Chinese population: A meta-analysis

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Liu, Mengying ^a   Bian, Chen ^a   Zhang, Jiqiang ^a   Wen, Feng ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; ISOPROTEIN;

AGED; ALLELE; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; ETHNOLOGY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; META ANALYSIS; PATHOLOGY; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; RISK FACTORS;

EID: 84896538125     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04383     Document Type: Article

References (58)

1. Selkoe, D. J. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81, 741-766 (2001). (Pubitemid 32267077)
2. Thies, W. & Bleiler, L. 2011 Alzheimer's disease facts and figures. Alzheimers Dement 7, 208-244 (2011).
3. Alzheimer's, A. 2012 Alzheimer's disease facts and figures. Alzheimers Dement 8, 131-168 (2012).
4. Siest, G. et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 41, 1068-1086 (1995).
5. Levy-Lahad, E. & Bird, T. D. Genetic factors in Alzheimer's disease: a review of recent advances. Ann Neurol 40, 829-840 (1996). (Pubitemid 27044600)
6. Mahley, R. W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630 (1988).
7. Mahley, R. W. & Rall, S. C. Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1, 507-537 (2000).
8. Zannis, V. I. et al. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res 23, 911-914 (1982). (Pubitemid 13244364)
9. Morrow, J. A. et al. Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. Biochemistry 39, 11657-11666 (2000).
10. Hauser, P. S. & Ryan, R. O. Impact of apolipoprotein E on Alzheimer's disease. Curr Alzheimer Res 10, 809-817 (2013).
11. Ghebremedhin, E. et al. Gender and age modify the association between APOE and AD-related neuropathology. Neurology 56, 1696-1701 (2001). (Pubitemid 32574569)
12. Millar, K., Nicoll, J. A., Thornhill, S., Murray, G. D. & Teasdale, G. M. Long term neuropsychological outcome after head injury: relation to APOE genotype. J Neurol Neurosurg Psychiatry 74, 1047-1052 (2003).
13. Lahoz, C. et al. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 154, 529-537 (2001). (Pubitemid 32232149)
14. Kim, J. et al. Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Abeta amyloidosis. J Exp Med 209, 2149-2156 (2012).
15. Verghese, P. B. et al. ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions. Proc Natl Acad Sci U S A 110, E1807-1816 (2013).
16. Claxton, A. et al. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. J Alzheimers Dis 35, 789-797 (2013).
17. Chen, D., Zhang, J. & Zhang, Z. Apolipoprotein E Gene Polymorphisms and Alzheimer's Disease. J G Genomics 30, 1167-1170 (2003).
18. Zhang, Y., Liu, Z. & Du, Y. Association between Apolipoprotein E gene polymorphism and Vascular dementia and Alzheimer's disease. Shandong Med J 22, 1-2 (2004).
19. Mai, Y., Luo, Y., Gu, H., Zhang, L. & LIN, J. Association between Interleukin-8 and Apolipoprotein E gene polymorphism and late-onset Alzheimer's disease. J sun yat-sen uni 1, 118-121 (2010).
20. Jia, J., Zhang, J., Xu, M. & Zhou, W. Association between the apolipoprotein E gene polymorphism and the genetic sensitivity of sporadic Alzheimer's disease. Chin J Geriatrics 4, 7-9 (2002).
21. Zhu, J., Xu, W. & Gao, Y. The association of apolipoprotein E and Alzheimer's disease. Practical Geriatrics 1, 23-25 (2000).
22. Jiang, W., Lv, Z. & Tan, L. Correlation between apolipoprotein E gene polymorphism s and Alzheimer's disease and vascular dementia. J Clin Neurology 6, 408-410 (2010).
23. He, S. R., Liu, D. G., Wang, S. & Xia, Y. J. Expression of apolipoprotein E in Alzheimer's disease and its significance. Chin J Pathology 34, 556-560 (2005).
24. Zhou, C., Xu, J. & He, J. Genetic correlation study between apolipoprotein E gene and Alzheimer's disease. Med J NDFNC 4, 244-246 (2003).
25. Huang, S., Lu, Y. & Chen, S. Inquiring relation between Apolipoprotein E Gene polymorphysm and the Alzheimer's disease. J M Clin Med Bio 1, 9-11 (2001).
26. Li, G., Zhao, M., Zuo, L., Liu, F. & Kuang, S. Polymorphism in the Apolipoprotein E Gene and Its Association with Sporadic Alzheimer Disease. J Guiyang Med 1, 24-26 (2006).
27. Bi, S. et al. The Relationship between ApoE Genotype, Serum Total Cholesterol Level, and Alzheimer's disease. Chin J neuroimmunology 1, 13-16 (2002).
28. Wu, P., Guo, Q., Chen, M., Zhou, Y. & Hong, Z. Relationship Between Apolipoprotein E Gene Polymorphism and Early-onset Alzheimer' s Disease. Chin J Clin Neurosci 3, 1168-1170 (2009).
29. Zhou, C., Cheng, X. & Xia, X. Relationship between Apolipoprotein E Polymorphism and Alzheimer's Disease in Chongqing. J Chin GP 27, 3115-3117 (2012).
30. Yang, J., Yu, F. & Wang, Y. Study of the polymorphisms of APOE gene in Alzheimer's disease and vascular dementia. Neuro Dis Mental H 2, 138-140 (2008).
31. Dong, X. The study of the relationship between AD and the ApoE polymorphism. Chin H Care Nutrition 2, 523-524 (2013).
32. Yang, L. Study on the association between Apolipoprotein E gene polymorphisms and sporadic Alzheimer's disease. Chin Mod Doctor 24, 89-90 (2008).
33. Duan, G., Guo, L. & Yang, L. Study on the Association of Apolipoprotein E-gene Polymorphism with Demented Patients. J Henan Med C 6, 559-561 (2009).
34. Lv, X. & Zhong, Y. Study on the relationship between apolipoprotein E gene polymorphism and mild cognitive impairment and Alzheimer's disease. Chin J Gerontology 5, 917-919 (2012).
35. Huang, H. M., Kuo, Y. M., Ou, H. C., Lin, C. C. & Chuo, L. J. Apolipoprotein E polymorphism in various dementias in Taiwan Chinese population. J Neural Transm 109, 1415-1421 (2002).
36. Wang, H. K. et al. Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer's disease and vascular dementia. J Neural Transm 113, 1499-1509 (2006). (Pubitemid 44435888)
37. Saunders, A. M. et al. Association of apolipoprotein E allele epsilon 4 with lateonset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472 (1993). (Pubitemid 23230526)
38. Schmechel, D. E. et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A 90, 9649-9653 (1993). (Pubitemid 23315843)
39. Strittmatter, W. J. et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90, 1977-1981 (1993). (Pubitemid 23069980)
40. Sando, S. B. et al. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. BMC Neurol 8, 9 (2008).
41. Rhinn, H. et al. Integrative genomics identifies APOE epsilon4 effectors in Alzheimer's disease. Nature 500, 45-50 (2013).
42. Genin, E. et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry 16, 903-907 (2011).
43. Ward, A. et al. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis. Neuroepidemiology 38, 1-17 (2012).
44. Mawuenyega, K. G. et al.Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 330, 1774 (2010).
45. Koffie, R. M. et al. Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-beta. Brain 135, 2155-2168 (2012).
46. Kim, J., Basak, J. M. & Holtzman, D. M. The role of apolipoprotein E in Alzheimer's disease. Neuron 63, 287-303 (2009).
47. Castellano, J. M. et al.Human apoE isoforms differentially regulate brain amyloidbeta peptide clearance. Sci Transl Med 3, 89ra57 (2011).
48. Hostage, C. A., Roy Choudhury, K., Doraiswamy, P. M., Petrella, J. R. & Alzheimer's Disease Neuroimaging, I. Dissecting the gene dose-effects of the APOE epsilon4 and epsilon2 alleles on hippocampal volumes in aging and Alzheimer's disease. PLoS One 8, e54483 (2013).
49. Berlau, D. J., Corrada, M. M., Head, E. & Kawas, C. H. APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Neurology 72, 829-834 (2009).
50. Reiman, E.M. et al. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A 106, 6820-6825 (2009).
51. Pomara, N. & Bruno, D. Potential effects of the APOE epsilon2 allele and of family history of Alzheimer's disease on brain amyloid-beta in normal elderly. Proc Natl Acad Sci U S A 108, E1007; author reply E1008 (2011).
52. Jofre-Monseny, L., Minihane, A. M. & Rimbach, G. Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res 52, 131-145 (2008). (Pubitemid 351211806)
53. Smith, J. D. Apolipoproteins and aging: emerging mechanisms. Ageing Res Rev 1, 345-365 (2002). (Pubitemid 38340329)
54. Jack, C. R. Jr. et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 132, 1355-1365 (2009).
55. McKhann, G. et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944 (1984). (Pubitemid 14076461)
56. Kim, S. M. et al. Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: effect of APOE epsilon4 allele. Neuroradiology 55, 25-34 (2013).
57. DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin Trials 7, 177-188 (1986). (Pubitemid 17189972)
58. Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22, 719-748 (1959).